Michael Alaia, MD
Sports Medicine · New York, NYNPI 1093910341
Payments from drug & device makers
What this record shows
The money is spread across several categories — speaking fees (51.8%), consulting fees and travel and lodging — rather than concentrated in one kind of arrangement. Arthrex accounts for 60.3% of it on its own, with 23 other manufacturers making up the rest. 2025 is the largest year on record at $102,825, 7.5 times the $13,733 reported in 2019. Among sports medicine clinicians in NY with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 247 payments — averaging $836.47 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$125K
- Bodycad USA Corp$22K
- Ranfac Corporation$21K
- Depuy Synthes Products, Inc.$15K
- Globus Medical$10K
- Suvon Surgical LLC$3K
- plus $11K from 18 others
Across 5 payments — averaging $25,960 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Arthrex$130K
Across 1 payment — averaging $4571.20 each. An ownership or investment interest held by the physician or an immediate family member.
- Overture Orthopaedics$5K
What the payments were for
- Consulting fees$70,99234%
- Speaking & faculty fees$107,00052%
- Travel & lodging$14,8717%
- Food & beverage$9,7395%
- Education$3,9882%
- Entertainment$190%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 95 | $124,511 |
| Bodycad USA Corp | 15 | $22,187 |
| Ranfac Corporation | 4 | $20,500 |
| Depuy Synthes Products, Inc. | 7 | $14,918 |
| Globus Medical | 4 | $9,685 |
| Suvon Surgical LLC | 24 | $3,396 |
| Medical Device Business Services, Inc. | 3 | $2,982 |
| Gotham Surgical Solutions & Devices, Inc. | 4 | $2,913 |
| Amgen | 52 | $1,025 |
| Brixton Biosciences, Inc. | 1 | $850 |
| Lifenet Health | 8 | $784 |
| Stryker | 5 | $637 |
| Linvatec Corporation | 6 | $483 |
| Johnson & Johnson | 7 | $423 |
| Joint Restoration Foundation, Inc. | 1 | $289 |
| Arcuro Medical Inc | 2 | $234 |
| Newclip USA LLC | 1 | $215 |
| Orthalign Inc | 1 | $167 |
| Miach Orthopaedics, Inc. | 1 | $161 |
| Smith+Nephew | 1 | $95 |
| Zimmer Biomet | 1 | $50 |
| Vericel Corporation | 1 | $47 |
| Overture Orthopaedics | 2 | $43 |
| IBSA Pharma Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RIGIDLOOP$17,843
- Fine Osteotomy$10,771
- XLIF$985
- Neural Ice$850
- GraftLink$439
- RAYOS$436
- Fien Osteotomy$406
- GraftLink TS$310
- LINVATEC SHOULDER ARTHROSCOPY$258
- SUPERBALL$234
- T2 ALPHA$170
- ORTHALIGN PLUS$167
- ICONIX$164
- VARIAX$154
- N/A$148
- KNEE & HIP IMPLANTS MENISCAL REPAIR FIBERSTITCH$145
- T2$140
- KNEE & HIP IMPLANTS INTERFERENCE SCREWS FASTTHREAD$117
- KNEE & HIP INSTRUMENTS ACL/PCL DISPOSABLES FLIP CUTTERS$115
- ALLOGRAFT TISSUE$112
How this compares
$206,609 in reported general payments places this provider in the 95th percentile of 403 sports medicine providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Meloxicam | 19 | $74 |
Paid to pharmacies, not to this prescriber.
Other sports medicine in New York
- Gregory DifeliceNew York$1.8M
- Theodore BlaineNew York$765K
- Robert MeislinNew York$720K
- Danyal NawabiNew York$592K
- Riley WilliamsNew York$512K
- Bryan KellyNew York$409K
- Samuel TaylorNew York$255K
- Eric StraussNew York$241K
- Michael FuNew York$210K
- Matthew TaoNew York$160K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.